Virpax Pharmaceuticals News

Maxim Group Downgrades Virpax Pharmaceuticals(VRPX.US) to Hold Rating

Futu NewsOct 9 20:31

Maxim Group Maintains Virpax Pharmaceuticals(VRPX.US) With Buy Rating, Maintains Target Price $3

Futu NewsAug 14 22:31

Virpax Pharmaceuticals' Promising Outlook: Buy Rating Justified by Strategic Financial Management and Innovative Pain Management Pipeline

TipRanksAug 14 21:48

Virpax Pharmaceuticals Analyst Ratings

BenzingaJul 19 21:22

Maxim Group Upgrades Virpax Pharmaceuticals to Buy, Announces $3 Price Target

BenzingaJul 19 21:22

Maxim Group: Downgraded Virpax Pharmaceuticals (VRPX.US) rating from buy to hold

Zhitong FinanceMay 22 23:50

Virpax Pharmaceuticals Analyst Ratings

BenzingaMay 22 23:50

Analysts Offer Insights on Healthcare Companies: Virpax Pharmaceuticals (VRPX) and I-MAB (IMAB)

TipRanksFeb 9 04:10

Promising Pipeline Developments and Market Opportunities Drive Buy Rating for Virpax Pharmaceuticals

TipRanksNov 17, 2023 23:26

Analysts Are Bullish on These Healthcare Stocks: Virpax Pharmaceuticals (VRPX), Kura Oncology (KURA)

TipRanksSep 29, 2023 00:10

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Virpax Pharmaceuticals (VRPX)

TipRanksSep 19, 2023 23:11

Maxim Group Remains a Buy on Virpax Pharmaceuticals (VRPX)

TipRanksAug 16, 2023 00:55

Maxim Group Sticks to Their Buy Rating for Virpax Pharmaceuticals (VRPX)

TipRanksMay 17, 2023 00:45

Maxim Group Keeps Their Buy Rating on Virpax Pharmaceuticals (VRPX)

TipRanksApr 7, 2023 00:35

Analysts' Top Healthcare Picks: Xenetic Biosciences (XBIO), Virpax Pharmaceuticals (VRPX)

TipRanksMar 24, 2023 00:16

Maxim Group Reaffirms Their Buy Rating on Virpax Pharmaceuticals (VRPX)

TipRanksFeb 15, 2023 00:10

Virpax Pharmaceuticals (VRPX) Receives a Buy From Maxim Group

TipRanksDec 16, 2022 20:40

Maxim Group Sticks to Its Buy Rating for Virpax Pharmaceuticals (VRPX)

TipRanksNov 12, 2022 00:55